bioAffinity Technologies Inc (NAS:BIAF)
$ 1.29 -0.05 (-3.76%) Market Cap: 19.96 Mil Enterprise Value: 21.16 Mil PE Ratio: 0 PB Ratio: 4.27 GF Score: 18/100

Q4 2022 bioAffinity Technologies Inc Earnings Call Transcript

Apr 03, 2023 / 01:00PM GMT
Operator

Good morning, and welcome to the bioAffinity Technologies Fourth Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Julie Anne Overton, Director of Corporate Communications. Please go ahead.

Julie Anne Overton
bioAffinity Technologies, Inc. - Director of Communications

Thank you, operator. Good morning, everyone, and welcome to today's conference call to discuss bioAffinity Technologies fourth quarter and full year 2022 financial results and our recent business progress.

Please note that certain information discussed during today's call is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that bioAffinity Technologies management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business.

These risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot